Home

RONALD ASBURY ANDREWS

CIK 1299153 · Former CEO · last filed 2026-07-01

RONALD ASBURY ANDREWS is a Former CEO who has filed 61 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for PSTV, was dated Jul 1, 2026. Across all open-market trades the lifetime net is +$43.3M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $431.5K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$431.5K

Companies

7

Total Filings

61

Lifetime Open-Market Net

$43.28M

Filer Profile

Reported Address
1375 ROZELLA WAY
GALLATIN, TN 37066
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PLUS THERAPEUTICS, INC. (PSTV) Delisted Director 922 $3.87 $3.6K $0 2 2026-07-01
PRPO Director 15,796 $27.32 $431.5K $0 18 2026-01-20
Insight Molecular Diagnostics Inc. (OCX) Delisted Former CEO 29,161 $3.20 $93.3K $43.07M 15 2022-12-09
Oxford Immunotec Global PLC (OXFD) Delisted Director 4,081 — — $0 6 2020-06-26
LIFE President, Medical Sciences 0 $40.25 $0 $154.8K 7 2014-02-04
CLARIENT, INC (CLRT) Delisted Vice-Chairman and CEO 0 — — $53.0K 7 2010-12-23
Cardiac Science CORP (CSCX) Delisted Director 0 — — $0 5 2010-12-06

Recent Filings

61 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-01 PLUS THERAPEUTICS, INC. (PSTV) Delisted Exer (M) +922 $0 EDGAR
2026-05-18 PLUS THERAPEUTICS, INC. (PSTV) Delisted Grant (A) — $0 EDGAR
2026-01-20 PRPO Grant (A) +568 $10.0K EDGAR
2026-01-06 PRPO Grant (A) — $0 EDGAR
2025-10-16 PRPO Grant (A) +568 $10.0K EDGAR
2025-07-18 PRPO Grant (A) +676 $10.0K EDGAR
2025-04-17 PRPO Grant (A) +1,785 $10.0K EDGAR
2025-01-16 PRPO Grant (A) +1,639 $10.0K EDGAR
2025-01-16 PRPO Grant (A) — $0 EDGAR
2024-10-17 PRPO Grant (A) +1,510 $10.0K EDGAR
Showing 1–10 of 61
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.